Laboratoires S.M.B.

Periodontal Disease and Oral Health

Research activity includes chronic periodontitis, with interest in adjunctive approaches alongside non-surgical periodontal treatment and the management of residual probing pocket depth.

  • Periodontitis
  • Vitamin D3 supplementation
  • Residual periodontal pockets

The sponsor’s oral-health portfolio reflects attention to inflammatory gum disease and supportive therapies in dental care.

Cardiovascular Risk and Lipid Disorders

Clinical research is focused on mixed dyslipidaemia in patients at high or very high coronary heart disease risk, with emphasis on achieving LDL cholesterol targets.

  • Rosuvastatin and fenofibrate combinations
  • Mixed dyslipidaemia
  • Coronary heart disease risk

This area addresses lipid-lowering strategies relevant to cardiometabolic care and prevention of atherosclerotic complications.

Sleep Medicine and Obstructive Sleep Apnea

The sponsor also funds research in obstructive sleep apnea, exploring inhaled treatment options for people with sleep-disordered breathing.

  • Obstructive sleep apnea
  • Dry-powder inhaler therapy
  • Sleep disorders

Interest in this field links respiratory delivery approaches with the management of nocturnal airway obstruction and related sleep symptoms.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study Comparing Rosuvastatin and Fenofibrate with Pravastatin and Fenofibrate for Patients with Mixed Dyslipidemia at High Risk of Heart Disease

    Recruiting

    1 1 1 1
    Greece
  • Study on the Effects of Vitamin D3 in Patients with Periodontitis and Vitamin D Deficiency

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study of Nacystelyn for Patients with Obstructive Sleep Apnea

    Not recruiting

    Investigated drugs:
    Belgium France